Windtree releases data from lung deposition study in non-human primates demonstrating uniform distribution of aerosolized KL4 surfactant in all regions of the lung

摘要

Windtree Therapeutics Inc (formerly Discovery Laboratories), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, has released data from a lung deposition study conducted in non-human primates (NHPs) demonstrating that the company's proprietary aerosol delivery system (ADS) is capable of delivering aerosolized KL4 surfactant throughout all regions of the lung.